Lv51
1102 积分 2022-08-03 加入
T-cell lymphomas in recipients of CAR-T cells: assessing risks and causalities
3天前
已完结
Engineering CAR-T therapies for autoimmune disease and beyond
3天前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
3天前
已完结
Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus
3天前
已完结
Clinical efficacy and autoantibody seroconversion with CD19-CAR T cell therapy in a patient with rheumatoid arthritis and coexisting myasthenia gravis
5天前
已完结
Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission
5天前
已完结
Anti–CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE
5天前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
5天前
已完结
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
5天前
已完结
Phagocytosis: a process that shapes immune responses to engulfed meals
6天前
已完结
皖公网安备34019202002308
